{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:32:07Z","timestamp":1788813127781,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"DOI":"10.1007\/s42000-026-00797-w","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:54:03Z","timestamp":1781276043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in diabetes technology: clinical implications, limitations, and future perspectives"],"prefix":"10.1007","author":[{"given":"Maria","family":"Apostolopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoris","family":"Effraimidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"797_CR1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00592-023-02037-8","volume":"60","author":"G Sartore","year":"2023","unstructured":"Sartore G, Ragazzi E, Caprino R, Lapolla A (2023) Long-term HbA1c variability and macro-\/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update. Acta Diabetol 60:721\u2013738. https:\/\/doi.org\/10.1007\/s00592-023-02037-8","journal-title":"Acta Diabetol"},{"key":"797_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","volume":"65","author":"E Teo","year":"2022","unstructured":"Teo E, Hassan N, Tam W, Koh S (2022) Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia 65:604\u2013619. https:\/\/doi.org\/10.1007\/s00125-021-05648-4","journal-title":"Diabetologia"},{"key":"797_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/diabetology6030017","volume":"6","author":"C Bender","year":"2025","unstructured":"Bender C, Vestergaard P, Cichosz SL (2025) The history, evolution and future of continuous glucose monitoring (CGM). Diabetology 6:17. https:\/\/doi.org\/10.3390\/diabetology6030017","journal-title":"Diabetology"},{"issue":"Suppl 1","key":"797_CR4","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1089\/dia.2009.0002","volume":"11","author":"E Cengiz","year":"2009","unstructured":"Cengiz E, Tamborlane WV (2009) A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther 11(Suppl 1):S11-16. https:\/\/doi.org\/10.1089\/dia.2009.0002","journal-title":"Diabetes Technol Ther"},{"key":"797_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/dia.2019.0434","volume":"22","author":"M Nguyen","year":"2020","unstructured":"Nguyen M, Han J, Spanakis EK et al (2020) A review of continuous glucose monitoring-based composite metrics for glycemic control. Diabetes Technol Ther 22:613\u2013622. https:\/\/doi.org\/10.1089\/dia.2019.0434","journal-title":"Diabetes Technol Ther"},{"key":"797_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1932296818812062","volume":"13","author":"G Freckmann","year":"2019","unstructured":"Freckmann G, Pleus S, Grady M et al (2019) Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices. J Diabetes Sci Technol 13:575\u2013583. https:\/\/doi.org\/10.1177\/1932296818812062","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1177\/19322968241275701","volume":"18","author":"DC Klonoff","year":"2024","unstructured":"Klonoff DC, Freckmann G, Pleus S et al (2024) The Diabetes Technology Society error grid and trend accuracy matrix for glucose monitors. J Diabetes Sci Technol 18:1346\u20131361. https:\/\/doi.org\/10.1177\/19322968241275701","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1177\/19322968251353540","volume":"19","author":"E Bach","year":"2025","unstructured":"Bach E, Fisker S, Christensen M et al (2025) Sampling interval influences glucose rate-of-change metrics. J Diabetes Sci Technol 19:1419\u20131420. https:\/\/doi.org\/10.1177\/19322968251353540","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1177\/19322968221084667","volume":"17","author":"MA Van Name","year":"2023","unstructured":"Van Name MA, Kanapka LG, DiMeglio LA et al (2023) Long-term continuous glucose monitor use in very young children with Type 1 Diabetes: one-year results from the SENCE study. J Diabetes Sci Technol 17:976\u2013987. https:\/\/doi.org\/10.1177\/19322968221084667","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/1932296818766381","volume":"12","author":"AT Vesco","year":"2018","unstructured":"Vesco AT, Jedraszko AM, Garza KP, Weissberg-Benchell J (2018) Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes. J Diabetes Sci Technol 12:792\u2013799. https:\/\/doi.org\/10.1177\/1932296818766381","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13300-017-0255-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R et al (2017) Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated Type 2 Diabetes. Diabetes Ther 8:573\u2013586. https:\/\/doi.org\/10.1007\/s13300-017-0255-6","journal-title":"Diabetes Ther"},{"key":"797_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/life15101543","volume":"15","author":"M-J Lee","year":"2025","unstructured":"Lee M-J, Seo B-J, Cho J-H (2025) Expanding the use of continuous glucose monitoring in Type 2 Diabetes Mellitus: Impact on glycemic control and metabolic health. Life Basel 15:1543. https:\/\/doi.org\/10.3390\/life15101543","journal-title":"Life Basel"},{"key":"797_CR13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00592-023-02097-w","volume":"60","author":"M Belli","year":"2023","unstructured":"Belli M, Bellia A, Sergi D et al (2023) Glucose variability: a new risk factor for cardiovascular disease. Acta Diabetol 60:1291\u20131299. https:\/\/doi.org\/10.1007\/s00592-023-02097-w","journal-title":"Acta Diabetol"},{"key":"797_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2337\/dc20-1862","volume":"44","author":"J Lu","year":"2021","unstructured":"Lu J, Wang C, Shen Y et al (2021) Time in range in relation to all-cause and cardiovascular mortality in patients with Type 2 Diabetes: A prospective cohort study. Diabetes Care 44:549\u2013555. https:\/\/doi.org\/10.2337\/dc20-1862","journal-title":"Diabetes Care"},{"key":"797_CR15","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1111\/dom.15608","volume":"26","author":"J Reed","year":"2024","unstructured":"Reed J, Dong T, Eaton E et al (2024) Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: a clinical trial. Diabetes Obes Metab 26:2881\u20132889. https:\/\/doi.org\/10.1111\/dom.15608","journal-title":"Diabetes Obes Metab"},{"key":"797_CR16","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.2337\/dc25-S007","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 7. Diabetes technology: standards of care in diabetes-2025. Diabetes Care 48:S146\u2013S166. https:\/\/doi.org\/10.2337\/dc25-S007","journal-title":"Diabetes Care"},{"key":"797_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1464-5491.2008.02486.x","volume":"25","author":"JC Pickup","year":"2008","unstructured":"Pickup JC, Sutton AJ (2008) Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 25:765\u2013774. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02486.x","journal-title":"Diabet Med"},{"key":"797_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.7326\/0003-4819-157-5-201209040-00508","volume":"157","author":"H-C Yeh","year":"2012","unstructured":"Yeh H-C, Brown TT, Maruthur N et al (2012) Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 157:336\u2013347. https:\/\/doi.org\/10.7326\/0003-4819-157-5-201209040-00508","journal-title":"Ann Intern Med"},{"key":"797_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/1932296816672689","volume":"11","author":"I Steineck","year":"2017","unstructured":"Steineck I, Ranjan A, N\u00f8rgaard K, Schmidt S (2017) Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes. J Diabetes Sci Technol 11:50\u201358. https:\/\/doi.org\/10.1177\/1932296816672689","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1002853","volume":"363","author":"RM Bergenstal","year":"2010","unstructured":"Bergenstal RM, Tamborlane WV, Ahmann A et al (2010) Effectiveness of sensor-augmented insulin-pump therapy in Type 1 Diabetes. N Engl J Med 363:311\u2013320. https:\/\/doi.org\/10.1056\/NEJMoa1002853","journal-title":"N Engl J Med"},{"key":"797_CR21","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1464-5491.2011.03256.x","volume":"28","author":"J Hermanides","year":"2011","unstructured":"Hermanides J, N\u00f8rgaard K, Bruttomesso D et al (2011) Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 Diabetes; a randomized controlled trial. Diabet Med 28:1158\u20131167. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03256.x","journal-title":"Diabet Med"},{"key":"797_CR22","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.2337\/dc14-0030","volume":"37","author":"SA Little","year":"2014","unstructured":"Little SA, Leelarathna L, Walkinshaw E et al (2014) Recovery of hypoglycemia awareness in long-standing Type 1 Diabetes: A multicenter 2 \u00d7 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 37:2114\u20132122. https:\/\/doi.org\/10.2337\/dc14-0030","journal-title":"Diabetes Care"},{"key":"797_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/JYPL3536","volume":"28","author":"A Asgharzadeh","year":"2024","unstructured":"Asgharzadeh A, Patel M, Connock M et al (2024) Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling. Health Technol Assess 28:1\u2013190. https:\/\/doi.org\/10.3310\/JYPL3536","journal-title":"Health Technol Assess"},{"issue":"Suppl 1","key":"797_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.70150","volume":"28","author":"S Di Molfetta","year":"2026","unstructured":"Di Molfetta S, Di Gioia L, Caruso I et al (2026) Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab 28(Suppl 1):3\u201312. https:\/\/doi.org\/10.1111\/dom.70150","journal-title":"Diabetes Obes Metab"},{"key":"797_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2022.0421","volume":"25","author":"SK Garg","year":"2023","unstructured":"Garg SK, Grunberger G, Weinstock R et al (2023) Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. Diabetes Technol Ther 25:1\u201312. https:\/\/doi.org\/10.1089\/dia.2022.0421","journal-title":"Diabetes Technol Ther"},{"key":"797_CR26","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.2337\/dc20-1447","volume":"43","author":"SA McAuley","year":"2020","unstructured":"McAuley SA, Lee MH, Paldus B et al (2020) Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with Type 1 diabetes: a randomized, controlled trial. Diabetes Care 43:3024\u20133033. https:\/\/doi.org\/10.2337\/dc20-1447","journal-title":"Diabetes Care"},{"key":"797_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S2213-8587(24)00284-5","volume":"13","author":"B Karges","year":"2025","unstructured":"Karges B, Rosenbauer J, Stahl-Pehe A et al (2025) Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2\u201320 years) with type 1 diabetes: a population-based study. The Lancet Diabetes & Endocrinology 13:88\u201396. https:\/\/doi.org\/10.1016\/S2213-8587(24)00284-5","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"797_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816665635","volume":"10","author":"D Lewis","year":"2016","unstructured":"Lewis D, Leibrand S, #OpenAPS Community (2016) Real-world use of open source artificial pancreas systems. J Diabetes Sci Technol 10:1411. https:\/\/doi.org\/10.1177\/1932296816665635","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S2213-8587(21)00267-9","volume":"10","author":"K Braune","year":"2022","unstructured":"Braune K, Lal RA, Petru\u017eelkov\u00e1 L et al (2022) Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 10:58\u201374. https:\/\/doi.org\/10.1016\/S2213-8587(21)00267-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"797_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00125-025-06644-8","volume":"69","author":"R Lal","year":"2026","unstructured":"Lal R, Braune K, Lewis DM et al (2026) Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems. Diabetologia 69:557\u2013567. https:\/\/doi.org\/10.1007\/s00125-025-06644-8","journal-title":"Diabetologia"},{"key":"797_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111910","volume":"218","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Lei M, Yang D et al (2024) Real-world efficacy and safety of open-source automated insulin delivery for people with type 1 diabetes mellitus: experience from Mainland China. Diabetes Res Clin Pract 218:111910. https:\/\/doi.org\/10.1016\/j.diabres.2024.111910","journal-title":"Diabetes Res Clin Pract"},{"key":"797_CR32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s40200-020-00547-8","volume":"19","author":"M Burnside","year":"2020","unstructured":"Burnside M, Lewis D, Crocket H et al (2020) CREATE (Community deRivEd AutomaTEd insulin delivery) trial. Randomised parallel arm open label clinical trial comparing automated insulin delivery using a mobile controller (AnyDANA-loop) with an open-source algorithm with sensor augmented pump therapy in type 1 diabetes. J Diabetes Metab Disord 19:1615\u20131629. https:\/\/doi.org\/10.1007\/s40200-020-00547-8","journal-title":"J Diabetes Metab Disord"},{"key":"797_CR33","doi-asserted-by":"publisher","first-page":"e14703","DOI":"10.1111\/dme.14703","volume":"39","author":"RM Garc\u00eda-Moreno","year":"2022","unstructured":"Garc\u00eda-Moreno RM, Ben\u00edtez-Valderrama P, Barquiel B et al (2022) Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med 39:e14703. https:\/\/doi.org\/10.1111\/dme.14703","journal-title":"Diabet Med"},{"key":"797_CR34","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.2337\/dc25-S015","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 15. Management of diabetes in pregnancy: standards of care in diabetes-2025. Diabetes Care 48:S306\u2013S320. https:\/\/doi.org\/10.2337\/dc25-S015","journal-title":"Diabetes Care"},{"key":"797_CR35","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","volume":"389","author":"TTM Lee","year":"2023","unstructured":"Lee TTM, Collett C, Bergford S et al (2023) Automated insulin delivery in women with pregnancy complicated by Type 1 Diabetes. N Engl J Med 389:1566\u20131578. https:\/\/doi.org\/10.1056\/NEJMoa2303911","journal-title":"N Engl J Med"},{"key":"797_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/dia.2023.0323","volume":"25","author":"J Lawton","year":"2023","unstructured":"Lawton J, Kimbell B, Closs M et al (2023) Listening to women: experiences of using closed-loop in Type 1 diabetes pregnancy. Diabetes Technol Ther 25:845\u2013855. https:\/\/doi.org\/10.1089\/dia.2023.0323","journal-title":"Diabetes Technol Ther"},{"key":"797_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","volume":"12","author":"K Benhalima","year":"2024","unstructured":"Benhalima K, Beunen K, Van Wilder N et al (2024) Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol 12:390\u2013403. https:\/\/doi.org\/10.1016\/S2213-8587(24)00089-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"797_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.diabres.2012.10.013","volume":"98","author":"N Achong","year":"2012","unstructured":"Achong N, Callaway L, d\u2019Emden M et al (2012) Insulin requirements in late pregnancy in women with type 1 diabetes mellitus: a retrospective review. Diabetes Res Clin Pract 98:414\u2013421. https:\/\/doi.org\/10.1016\/j.diabres.2012.10.013","journal-title":"Diabetes Res Clin Pract"},{"key":"797_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14207357","volume":"14","author":"R D\u2019Souza","year":"2025","unstructured":"D\u2019Souza R, Ashraf R, Sayfi S et al (2025) Falling third-trimester insulin requirements in diabetic pregnancies and adverse pregnancy outcomes: a systematic review and meta-analysis. J Clin Med 14:7357. https:\/\/doi.org\/10.3390\/jcm14207357","journal-title":"J Clin Med"},{"key":"797_CR40","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2337\/dc17-0391","volume":"40","author":"S Padmanabhan","year":"2017","unstructured":"Padmanabhan S, Lee VW, Mclean M et al (2017) The association of falling insulin requirements with maternal biomarkers and placental dysfunction: a prospective study of women with preexisting diabetes in pregnancy. Diabetes Care 40:1323\u20131330. https:\/\/doi.org\/10.2337\/dc17-0391","journal-title":"Diabetes Care"},{"key":"797_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14217737","volume":"14","author":"M Vainder","year":"2025","unstructured":"Vainder M, Natt N, Sayyar P et al (2025) Falling third trimester insulin requirements and adverse pregnancy outcomes in individuals with pre-existing diabetes: a retrospective cohort study. J Clin Med 14:7737. https:\/\/doi.org\/10.3390\/jcm14217737","journal-title":"J Clin Med"},{"key":"797_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3771","volume":"40","author":"N Dori-Dayan","year":"2024","unstructured":"Dori-Dayan N, Cukierman\u2010Yaffe T, Zemet R et al (2024) Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump. Diabetes Metab Res Rev 40:e3771. https:\/\/doi.org\/10.1002\/dmrr.3771","journal-title":"Diabetes Metab Res Rev"},{"key":"797_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110800","volume":"202","author":"L Albert","year":"2023","unstructured":"Albert L, Romero A, Capel I et al (2023) Off-label use of an automated insulin delivery system in pregnant women with type 1 diabetes. Diabetes Res Clin Pract 202:110800. https:\/\/doi.org\/10.1016\/j.diabres.2023.110800","journal-title":"Diabetes Res Clin Pract"},{"key":"797_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/dia.2022.0540","volume":"25","author":"ED Szmuilowicz","year":"2023","unstructured":"Szmuilowicz ED, Levy CJ, Buschur EO, Polsky S (2023) Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by Diabetes. Diabetes Technol Ther 25:363\u2013373. https:\/\/doi.org\/10.1089\/dia.2022.0540","journal-title":"Diabetes Technol Ther"},{"key":"797_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00540-021-03024-5","volume":"36","author":"S Matsumoto","year":"2022","unstructured":"Matsumoto S, Omiya H, Fujinaka W, Morimatsu H (2022) Association between intraoperative hyperglycemia and postoperative end-organ dysfunctions after cardiac surgery: a retrospective observational study. J Anesth 36:174\u2013184. https:\/\/doi.org\/10.1007\/s00540-021-03024-5","journal-title":"J Anesth"},{"key":"797_CR46","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","volume":"360","author":"NICE-SUGAR Study Investigators","year":"2009","unstructured":"Study Investigators NICE-SUGAR, Finfer S, Chittock DR et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283\u20131297. https:\/\/doi.org\/10.1056\/NEJMoa0810625","journal-title":"N Engl J Med"},{"key":"797_CR47","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.2337\/dc25-S016","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 16. Diabetes care in the hospital: Standards of Care in Diabetes-2025. Diabetes Care 48:S321\u2013S334. https:\/\/doi.org\/10.2337\/dc25-S016","journal-title":"Diabetes Care"},{"key":"797_CR48","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1111\/dom.16583","volume":"27","author":"L Carlier","year":"2025","unstructured":"Carlier L, De Ponthaud C, Jacqueminet S et al (2025) Perioperative use and accuracy of continuous glucose monitoring: a systematic review. Diabetes Obes Metab 27:5393\u20135408. https:\/\/doi.org\/10.1111\/dom.16583","journal-title":"Diabetes Obes Metab"},{"key":"797_CR49","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/1932296820954163","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Umpierrez GE, Rushakoff RJ et al (2020) Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol 14:1035\u20131064. https:\/\/doi.org\/10.1177\/1932296820954163","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR50","doi-asserted-by":"publisher","unstructured":"Prince N, Ramsay T, Shorr R et al (2026) Systematic Review of Continuous Glucose Monitor Accuracy in the Hypoglycemia Range for Non-Critical Care Ward Hospitalized People Living With Diabetes. J Diabetes Sci Technol 19322968251412482. https:\/\/doi.org\/10.1177\/19322968251412482","DOI":"10.1177\/19322968251412482"},{"key":"797_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70408","author":"L van Baal","year":"2025","unstructured":"van Baal L, Raess L, Mathew A et al (2025) Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia. Diabetes Obes Metab. https:\/\/doi.org\/10.1111\/dom.70408","journal-title":"Diabetes Obes Metab"},{"key":"797_CR52","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2337\/dc24-1069","volume":"48","author":"MN Munshi","year":"2025","unstructured":"Munshi MN, Slyne C, Adam A et al (2025) Continuous Glucose Monitoring With Geriatric Principles in Older Adults With Type 1 Diabetes and Hypoglycemia: A Randomized Controlled Trial. Diabetes Care 48:694\u2013702. https:\/\/doi.org\/10.2337\/dc24-1069","journal-title":"Diabetes Care"},{"key":"797_CR53","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400200","volume":"4","author":"YC Kudva","year":"2025","unstructured":"Kudva YC, Henderson RJ, Kanapka LG et al (2025) Automated insulin delivery in older adults with Type 1 diabetes. NEJM Evid 4:EVIDoa2400200. https:\/\/doi.org\/10.1056\/EVIDoa2400200","journal-title":"NEJM Evid"},{"key":"797_CR54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(16)32567-3","volume":"389","author":"FH El-Khatib","year":"2017","unstructured":"El-Khatib FH, Balliro C, Hillard MA et al (2017) Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet 389:369\u2013380. https:\/\/doi.org\/10.1016\/S0140-6736(16)32567-3","journal-title":"Lancet"},{"key":"797_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gerinurse.2024.06.041","volume":"59","author":"J Ahn","year":"2024","unstructured":"Ahn J, Yang Y, Park G (2024) Advancing elderly diabetes care: exploring the usability and acceptance of continuous glucose monitoring (CGM). Geriatr Nurs 59:15\u201325. https:\/\/doi.org\/10.1016\/j.gerinurse.2024.06.041","journal-title":"Geriatr Nurs"},{"key":"797_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/dsi21-0016","volume":"35","author":"NA Allen","year":"2022","unstructured":"Allen NA, Bristol A, Grigorian EG et al (2022) SHARE plus: delivering a telehealth CGM data-sharing intervention to older adults and their care partners. Diabetes Spectr 35:16\u201325. https:\/\/doi.org\/10.2337\/dsi21-0016","journal-title":"Diabetes Spectr"},{"key":"797_CR57","doi-asserted-by":"publisher","DOI":"10.2196\/35687","volume":"7","author":"NA Allen","year":"2022","unstructured":"Allen NA, Litchman ML, Chamberlain J et al (2022) Continuous glucose monitoring data sharing in older adults with type 1 diabetes: pilot intervention study. JMIR Diabetes 7:e35687. https:\/\/doi.org\/10.2196\/35687","journal-title":"JMIR Diabetes"},{"key":"797_CR58","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0108","volume":"12","author":"K Lingen","year":"2023","unstructured":"Lingen K, Pikounis T, Bellini N, Isaacs D (2023) Advantages and disadvantages of connected insulin pens in diabetes management. Endocr Connect 12:e230108. https:\/\/doi.org\/10.1530\/EC-23-0108","journal-title":"Endocr Connect"},{"key":"797_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzaf046","volume":"37","author":"MA Barchiesi","year":"2025","unstructured":"Barchiesi MA, Calabrese A, Costa R et al (2025) Continuous glucose monitoring in type 2 diabetes: a systematic review of barriers and opportunities for care improvement. Int J Qual Health Care 37:mzaf046. https:\/\/doi.org\/10.1093\/intqhc\/mzaf046","journal-title":"Int J Qual Health Care"},{"key":"797_CR60","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae125","volume":"8","author":"K Ni","year":"2024","unstructured":"Ni K, Tampe CA, Sol K et al (2024) Continuous glucose monitor: reclaiming Type 2 diabetes self-efficacy and mitigating disparities. J Endocr Soc 8:bvae125. https:\/\/doi.org\/10.1210\/jendso\/bvae125","journal-title":"J Endocr Soc"},{"key":"797_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/children12121668","volume":"12","author":"S Giza","year":"2025","unstructured":"Giza S, Kotanidou EP, Tsinopoulou VR et al (2025) Can glucose alarm fatigue threaten the absolute clinical benefit of continuous glucose monitoring in optimal glucose management in children and adolescents with Type 1 Diabetes? A narrative review. Children Basel 12:1668. https:\/\/doi.org\/10.3390\/children12121668","journal-title":"Children Basel"},{"key":"797_CR62","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1021\/acsanm.4c06474","volume":"8","author":"Y-H Chiu","year":"2025","unstructured":"Chiu Y-H, Rinawati M, Chang L-Y et al (2025) Carbon Nitride quantum dots\/Polyaniline nanocomposites for non-invasive glucose monitoring using wearable sweat biosensor. ACS Appl Nano Mater 8:2340\u20132351. https:\/\/doi.org\/10.1021\/acsanm.4c06474","journal-title":"ACS Appl Nano Mater"},{"key":"797_CR63","first-page":"3825","volume":"15","author":"J Wu","year":"2023","unstructured":"Wu J, Liu Y, Yin H, Guo M (2023) A new generation of sensors for non-invasive blood glucose monitoring. Am J Transl Res 15:3825\u20133837","journal-title":"Am J Transl Res"},{"key":"797_CR64","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1089\/dia.2021.0268","volume":"23","author":"D Isaacs","year":"2021","unstructured":"Isaacs D, Bellini NJ, Biba U et al (2021) Health care disparities in use of continuous glucose monitoring. Diabetes Technol Ther 23:S81\u2013S87. https:\/\/doi.org\/10.1089\/dia.2021.0268","journal-title":"Diabetes Technol Ther"},{"key":"797_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2337\/dc22-1055","volume":"46","author":"S Kanbour","year":"2023","unstructured":"Kanbour S, Jones M, Abusamaan MS et al (2023) Racial Disparities in Access and Use of Diabetes Technology Among Adult Patients With Type 1 Diabetes in a U.S. Academic Medical Center. Diabetes Care 46:56\u201364. https:\/\/doi.org\/10.2337\/dc22-1055","journal-title":"Diabetes Care"},{"key":"797_CR66","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45316","volume":"7","author":"A Wallia","year":"2024","unstructured":"Wallia A, Agarwal S, Owen AL et al (2024) Disparities in continuous glucose monitoring among patients receiving care in Federally Qualified Health Centers. JAMA Netw Open 7:e2445316. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45316","journal-title":"JAMA Netw Open"},{"key":"797_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1083145","volume":"14","author":"EA Vrany","year":"2023","unstructured":"Vrany EA, Hill-Briggs F, Ephraim PL et al (2023) Continuous glucose monitors and virtual care in high-risk, racial and ethnic minority populations: toward promoting health equity. Front Endocrinol (Lausanne) 14:1083145. https:\/\/doi.org\/10.3389\/fendo.2023.1083145","journal-title":"Front Endocrinol (Lausanne)"},{"key":"797_CR68","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/dia.2024.0647","volume":"27","author":"EH Sern\u00e9","year":"2025","unstructured":"Sern\u00e9 EH, Buompensiere MI, de Portu S et al (2025) Automated Insulin Delivery Versus Standard of Care in the Management of People Living with Type 1 Diabetes and HbA1c\u2009<\u20098%: A Cost-Utility Analysis in The Netherlands. Diabetes Technol Ther 27:631\u2013640. https:\/\/doi.org\/10.1089\/dia.2024.0647","journal-title":"Diabetes Technol Ther"},{"key":"797_CR69","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2025-0125","volume":"14","author":"M Willis","year":"2025","unstructured":"Willis M, Nilsson A, Alshannaq H et al (2025) The cost-effectiveness of real-time continuous glucose monitoring versus intermittently scanned continuous glucose monitoring in individuals with insulin-treated Type 2 diabetes mellitus in Canada. J Comp Eff Res 14:e250125. https:\/\/doi.org\/10.57264\/cer-2025-0125","journal-title":"J Comp Eff Res"},{"key":"797_CR70","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1177\/193229681200600429","volume":"6","author":"L Heinemann","year":"2012","unstructured":"Heinemann L, Krinelke L (2012) Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol 6:954\u2013964. https:\/\/doi.org\/10.1177\/193229681200600429","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR71","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/dia.2025.0062","volume":"27","author":"N Kadiyala","year":"2025","unstructured":"Kadiyala N, Lakshman R, Allen J et al (2025) Fully closed-loop improves glycemic control compared with pump with CGM in adolescents with Type 1 diabetes and HbA1c above target: a two-center, randomized crossover study. Diabetes Technol Ther 27:719\u2013727. https:\/\/doi.org\/10.1089\/dia.2025.0062","journal-title":"Diabetes Technol Ther"},{"key":"797_CR72","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.2337\/dc23-0728","volume":"46","author":"CK Boughton","year":"2023","unstructured":"Boughton CK, Hartnell S, Lakshman R et al (2023) Fully closed-loop glucose control compared with insulin pump therapy with continuous glucose monitoring in adults with Type 1 Diabetes and suboptimal glycemic control: a single-center, randomized, crossover study. Diabetes Care 46:1916\u20131922. https:\/\/doi.org\/10.2337\/dc23-0728","journal-title":"Diabetes Care"},{"key":"797_CR73","doi-asserted-by":"publisher","unstructured":"Wilkinson TM, de Bock MI, Meier R et al (2025) Fully Closed-Loop Insulin Delivery with High-Carbohydrate and High-Fat Meals Using the Tandem Freedom System. J Diabetes Sci Technol 19322968251389966. https:\/\/doi.org\/10.1177\/19322968251389966","DOI":"10.1177\/19322968251389966"},{"key":"797_CR74","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41591-022-02144-z","volume":"29","author":"AB Daly","year":"2023","unstructured":"Daly AB, Boughton CK, Nwokolo M et al (2023) Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nat Med 29:203\u2013208. https:\/\/doi.org\/10.1038\/s41591-022-02144-z","journal-title":"Nat Med"},{"key":"797_CR75","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2337\/dc20-2106","volume":"44","author":"H Blauw","year":"2021","unstructured":"Blauw H, Onvlee AJ, Klaassen M et al (2021) Fully closed loop glucose control with a bihormonal artificial pancreas in adults with Type 1 Diabetes: an outpatient, randomized, crossover trial. Diabetes Care 44:836\u2013838. https:\/\/doi.org\/10.2337\/dc20-2106","journal-title":"Diabetes Care"},{"key":"797_CR76","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/dia.2023.0532","volume":"26","author":"S Lebech Cichosz","year":"2024","unstructured":"Lebech Cichosz S, Hasselstr\u00f8m Jensen M, Schou Olesen S (2024) Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Continuous Glucose Monitoring. Diabetes Technol Ther 26:457\u2013466. https:\/\/doi.org\/10.1089\/dia.2023.0532","journal-title":"Diabetes Technol Ther"},{"key":"797_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1571362","volume":"16","author":"C Ji","year":"2025","unstructured":"Ji C, Jiang T, Liu L et al (2025) Continuous glucose monitoring combined with artificial intelligence: redefining the pathway for prediabetes management. Front Endocrinol (Lausanne) 16:1571362. https:\/\/doi.org\/10.3389\/fendo.2025.1571362","journal-title":"Front Endocrinol (Lausanne)"},{"key":"797_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253125","volume":"16","author":"WPTM van Doorn","year":"2021","unstructured":"van Doorn WPTM, Foreman YD, Schaper NC et al (2021) Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study. PLoS One 16:e0253125. https:\/\/doi.org\/10.1371\/journal.pone.0253125","journal-title":"PLoS One"},{"key":"797_CR79","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/dia.2019.0411","volume":"22","author":"P Adolfsson","year":"2020","unstructured":"Adolfsson P, Hartvig NV, Kaas A et al (2020) Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen. Diabetes Technol Ther 22:709\u2013718. https:\/\/doi.org\/10.1089\/dia.2019.0411","journal-title":"Diabetes Technol Ther"},{"key":"797_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/19322968221104142","volume":"18","author":"NR Ekberg","year":"2024","unstructured":"Ekberg NR, Hartvig NV, Kaas A et al (2024) Smart pen exposes missed basal insulin injections and reveals the impact on glycemic control in adults with type 1 diabetes. J Diabetes Sci Technol 18:66\u201373. https:\/\/doi.org\/10.1177\/19322968221104142","journal-title":"J Diabetes Sci Technol"},{"key":"797_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/dia.2023.0365","volume":"26","author":"J MacLeod","year":"2024","unstructured":"MacLeod J, Im GH, Smith M, Vigersky RA (2024) Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World Evidence of the InPen Smart Insulin Pen. Diabetes Technol Ther 26:33\u201339. https:\/\/doi.org\/10.1089\/dia.2023.0365","journal-title":"Diabetes Technol Ther"}],"updated-by":[{"DOI":"10.1007\/s42000-026-00803-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000}}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-026-00797-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00797-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:42:01Z","timestamp":1785476521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-026-00797-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":81,"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1007\/s42000-026-00797-w","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"15 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s42000-026-00803-1","URL":"https:\/\/doi.org\/10.1007\/s42000-026-00803-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There is no conflict of interest related to this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}